JOLIEVE Trademark

Trademark Overview


On Tuesday, April 4, 2023, a trademark application was filed for JOLIEVE with the United States Patent and Trademark Office. The USPTO has given the JOLIEVE trademark a serial number of 97872262. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Shionogi & Co., Ltd.. The JOLIEVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis
jolieve

General Information


Serial Number97872262
Word MarkJOLIEVE
Filing DateTuesday, April 4, 2023
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7207745
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of cardiovascular diseases, diabetes, obesity, cancer, endocrine disorders, hormonal diseases and disorders, urological disorders, sexual dysfunction, HIV and AIDs, central nervous systems diseases and disorders, peripheral nervous system diseases and disorders, osteoporosis, rheumatism, neurological disorders, pain, gastrointestinal disorders, respiratory diseases and disorders, allergies, bacterial disorders, viral disorders, fungal disorders, infectious diseases, inflammationn and inflammatory diseases, sepsis, immunological disorders, musculoskeletal disorders, thrombocytopenia, disease and disorders of the liver, and opioid-induced constipation; pharmaceutical preparations for treating allergic rhinitis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 10, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameShionogi & Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Party NameShionogi & Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Party NameShionogi & Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka-shi, Osaka 541-0045
JP

Trademark Events


Event DateEvent Description
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 7, 2023ASSIGNED TO EXAMINER
Friday, April 14, 2023TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Friday, April 14, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 10, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 7, 2023NEW APPLICATION ENTERED